Objectives Sufferers experiencing invasive mycoses receive concomitant antifungal therapy and antibacterial realtors often. such as for example levofloxacin and moxifloxacin, and antifungal realtors against and pharmacodynamic connections between ciprofloxacin, moxifloxacin or levofloxacin with amphotericin B, fluconazole, voriconazole and caspofungin against and (CA 362, CA 8621 and CA 5685) and [AF 2025, AF 4215 (ATCC MYA-3626)… Continue reading Objectives Sufferers experiencing invasive mycoses receive concomitant antifungal therapy and antibacterial